Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
Yanmei Zeng, Chenzhong Li, Meiping Guan, et al.
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Young-Sun Lee, Hee‐Sook Jun
Mediators of Inflammation (2016) Vol. 2016, pp. 1-11
Open Access | Times Cited: 382
Sirtuin 6 Expression and Inflammatory Activity in Diabetic Atherosclerotic Plaques: Effects of Incretin Treatment
Maria Luisa Balestrieri, Maria Rosaria Rizzo, Michelangela Barbieri, et al.
Diabetes (2014) Vol. 64, Iss. 4, pp. 1395-1406
Open Access | Times Cited: 186
DPP4 in Cardiometabolic Disease
Jixin Zhong, Andrei Maiseyeu, Stephen N. Davis, et al.
Circulation Research (2015) Vol. 116, Iss. 8, pp. 1491-1504
Open Access | Times Cited: 166
The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
Angelo Avogaro, Gian Paolo Fadini
Diabetes Care (2014) Vol. 37, Iss. 10, pp. 2884-2894
Open Access | Times Cited: 148
Effects and mechanisms of Danshen-Shanzha herb-pair for atherosclerosis treatment using network pharmacology and experimental pharmacology
Jianyong Zhang, Rixin Liang, Lan Wang, et al.
Journal of Ethnopharmacology (2018) Vol. 229, pp. 104-114
Closed Access | Times Cited: 88
Sitagliptin, diabetes mellitus, and heart failure: an in-depth review of sitagliptin therapy and heart failure in patients with diabetes mellitus
Mohammadjavad Sotoudeheian, Seyed‐Mohamad‐Sadegh Mirahmadi, Pedram Salehi Darjani, et al.
Diabetology International (2025)
Closed Access | Times Cited: 1
Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells
Dan Wang, Meiping Guan, Zongji Zheng, et al.
Cellular Physiology and Biochemistry (2015) Vol. 36, Iss. 6, pp. 2093-2107
Open Access | Times Cited: 88
Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
Katarina Tomović, Jelena Lazarević, Gordana Kocić, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 404-422
Open Access | Times Cited: 73
Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes
Zeqing Zhang, Xi Chen, Puhan Lu, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 70
DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages
Christoph Brenner, Wolfgang-M. Franz, Sarah Kühlenthal, et al.
International Journal of Cardiology (2015) Vol. 199, pp. 163-169
Closed Access | Times Cited: 69
A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression
Hwan‐Jin Hwang, Tae Woo Jung, Baek‐hui Kim, et al.
Biochemical Pharmacology (2015) Vol. 98, Iss. 1, pp. 157-166
Closed Access | Times Cited: 68
The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy
Zongji Zheng, Meiping Guan, Yijie Jia, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 65
DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome
Yochai Birnbaum, Dat Q. Tran, Mandeep Bajaj, et al.
Basic Research in Cardiology (2019) Vol. 114, Iss. 5
Closed Access | Times Cited: 62
In Situ Regulation of Macrophage Polarization to Enhance Osseointegration Under Diabetic Conditions Using Injectable Silk/Sitagliptin Gel Scaffolds
Geng Xiang, Keyin Liu, Tianji Wang, et al.
Advanced Science (2020) Vol. 8, Iss. 3
Open Access | Times Cited: 60
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
Qingguo Lü, Xuan Li, Jia Liu, et al.
Bioscience Reports (2019) Vol. 39, Iss. 2
Open Access | Times Cited: 59
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
Michael Razavi, Yingying Wei, Xiaoquan Rao, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 31
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Allison B. Herman, Dimitrios Tsitsipatis, Carlos Anerillas, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 18
High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells
Meng Xue, Yang Li, Fang Hu, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 498, Iss. 1, pp. 38-44
Closed Access | Times Cited: 56
Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice
Hotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
Vascular Pharmacology (2015) Vol. 79, pp. 16-23
Closed Access | Times Cited: 53
Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats
Hiromichi Murase, Atsushi Kuno, Takayuki Miki, et al.
Cardiovascular Diabetology (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 53
Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase
Songtao Tang, Huan Su, Qiu Zhang, et al.
International Journal of Molecular Medicine (2016) Vol. 37, Iss. 6, pp. 1558-1566
Open Access | Times Cited: 53
Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms
Yuling Tian, Tao Chen, Yan Wu, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 53
Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation
Seung Hee Choi, Sungmi Park, Chang Joo Oh, et al.
Vascular Pharmacology (2015) Vol. 73, pp. 11-19
Closed Access | Times Cited: 51
Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial in vivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits
Mitsumasa Sudo, Yuxin Li, Takafumi Hiro, et al.
Atherosclerosis (2017) Vol. 265, pp. 283-291
Closed Access | Times Cited: 50
Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals
Tsutomu Hirano, Yusaku Mori
Journal of Diabetes Investigation (2016) Vol. 7, Iss. S1, pp. 80-86
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top